Wow, there are clearly too many people in this thread who are incapable of READING and lack analytical skills.
"I would have expected assessments to be growing exponentially as more clients start using Painchek"
I was asking a question in my original post about the growth being the same each quarter (yes, a consistent linear number of 20-25k) and so far NO ONE here seems to be able to explain why a company like this should be growing in such a linear way when it really should be exponential.
Instead, too many of you leap to insults and simply show your lack of analytical skills to assess numbers right in front of you.
Is Painchek an early growth stock or not?
Linear growth is NOT that impressive here, and anyone who thinks otherwise really doesn't understand the trajectories of successful companies in their early years.
Furthermore, I never said Painchek stated shareholders should expect exponential growth, so go improve your reading and comprehension skills. As a shareholder, I find their consistent linear growth very disappointing and it is NOT good enough.
Perhaps others see it the same way as me and the SP is simply reflecting this.
Add to My Watchlist
What is My Watchlist?
